Physician
Solar Health, P.A.
Solar Health, P.A. was paid $25K by Medicaid between Jan 2018 and Nov 2022, across 21 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 43% of everything it billed.
33Billing provider infoSOLAR HEALTH, P.A.
FARMERS BRANCH, TX 75234
FARMERS BRANCH, TX 75234
33aNPI1376724948assigned 11/23/2007
33bProvider typePsychiatry Physician
28Total paid$25K
24GClaims19,670
24DCodes billed21
24AFirst – last monthJan 2018 – Nov 2022
Compared with peers
Next to other Psychiatry Physician providers in Texas
Rank by total paid#200 of 311
Median peer was paid$63K
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,826 | $1K | |
| 2019 | 4,131 | $6K | |
| 2020 | 5,299 | $6K | |
| 2021 | 4,299 | $6K | |
| 2022 | 2,115 | $7K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 43% | 1,895 | 1,797 | $11K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 2,374 | 2,165 | $8K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 13% | 227 | 153 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.7% | 36 | 35 | $2K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.6% | 234 | 153 | $642.17 |
| 20610 | 1.8% | 117 | 94 | $444.94 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1.0% | 2,516 | 2,394 | $256.50 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,751 | 4,579 | $101.79 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 234 | 153 | $56.90 |
| 99441 | <1% | 28 | 22 | $53.72 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,260 | 1,791 | $51.93 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,827 | 896 | $1.57 |
9 more codes
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 285 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 158 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 135 | $0.00 |
| 27096 | 0% | 17 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 2,186 | $0.00 |
| 94760 | 0% | 112 | $0.00 | |
| 1111F | 0% | 222 | $0.00 | |
| 64493 | 0% | 42 | $0.00 | |
| 64494 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRASHEED, HAROON (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Grand Anesthesia PLLC | Grand Rapids, MI | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.